Skip to main content
Premium Trial:

Request an Annual Quote

Europroteome in Collaboration with Altana Pharma

NEW YORK, July 1 (GenomeWeb News) - Berlin-based Europroteome and Altana Pharma have entered a collaboration to evaluate approaches to molecular profiling of tissue specimens from cancer patients.

Europroteome will apply its proprietary collection of purified cancer cells to analyze molecular expression of panel of cancer targets, which will then be compared with clinical data to assess disease-associated expression signatures. This data will be applied to define molecular targets for the development of therapeutics and diagnostics.

Financial terms were not disclosed.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.